Paul Virgo

2.5k total citations
24 papers, 913 citations indexed

About

Paul Virgo is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paul Virgo has authored 24 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 8 papers in Immunology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paul Virgo's work include Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Paul Virgo is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Paul Virgo collaborates with scholars based in United Kingdom, United States and Italy. Paul Virgo's co-authors include David Grimwade, Sylvie Freeman, Robert K. Hills, Alan K. Burnett, Nigel H. Russell, Roger S. Evely, R J Lock, Allison Blair, Pamela Kearns and Charlotte V. Cox and has published in prestigious journals such as Journal of Clinical Oncology, Blood and European Respiratory Journal.

In The Last Decade

Paul Virgo

23 papers receiving 899 citations

Peers

Paul Virgo

HEMAT

PHEOH

GENET

ONCOL

Paolo Gorello Italy

A Butturini United States

Silja Röttgers Germany

Nicoletta Coccaro Italy

OA Haas Austria

Karin B. Gale United Kingdom

LW Dow United States

SF Williams United States

Mineo Kurokawa Japan

Fabian Zohren Germany

Paolo Gorello Italy

Paul Virgo

568 ×1.0

HEMAT

549 ×1.9

257 ×0.9

PHEOH

175 ×0.8

GENET

91 ×0.6

ONCOL

Citations per year, relative to Paul Virgo Paul Virgo (= 1×) peers Paolo Gorello

Countries citing papers authored by Paul Virgo

Since Specialization

Citations

This map shows the geographic impact of Paul Virgo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Virgo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Virgo more than expected).

Fields of papers citing papers by Paul Virgo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Virgo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Virgo. The network helps show where Paul Virgo may publish in the future.

Co-authorship network of co-authors of Paul Virgo

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Virgo. A scholar is included among the top collaborators of Paul Virgo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Virgo. Paul Virgo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Amy, Alice Halliday, James L. N. Wood, et al.. (2025). High Mycobacterium bovis Exposure but Low IGRA Positivity in UK Farm Workers. Zoonoses and Public Health. 72(4). 369–378.

Kelleher, Peter, Louise Greathead, Liam Whitby, et al.. (2024). European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation. Cytometry Part B Clinical Cytometry. 106(6). 424–436. 2 indexed citations

Tandon, Sneha, et al.. (2021). Paediatric ambiguous lineage leukaemia with monocytic differentiation at diagnosis: case series and review of literature. British Journal of Haematology. 196(3). e34–e39. 2 indexed citations

Fonseka, Duneesha de, David Arnold, Louise Stadon, et al.. (2018). A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma. BMC Cancer. 18(1). 199–199. 18 indexed citations

Freeman, Sylvie, Robert K. Hills, Paul Virgo, et al.. (2018). Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations. Journal of Clinical Oncology. 36(15). 1486–1497. 136 indexed citations

Dixon, Giles, Rahul Bhatnagar, Natalie Zahan-Evans, et al.. (2017). A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions. Respiration. 95(2). 98–105. 11 indexed citations

Redondo, Juliana, Kevin Kemp, Paul Virgo, et al.. (2017). Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro. Multiple Sclerosis Journal. 24(7). 919–931. 39 indexed citations

Khan, Naeem, Robert K. Hills, Paul Virgo, et al.. (2016). Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia. Leukemia. 31(5). 1059–1068. 50 indexed citations

Bright, Philip, et al.. (2014). Laboratory clues to immunodeficiency; missed chances for early diagnosis?. Journal of Clinical Pathology. 68(1). 1–5. 9 indexed citations

10.

Freeman, Sylvie, Paul Virgo, David Grimwade, et al.. (2013). Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia. Journal of Clinical Oncology. 31(32). 4123–4131. 228 indexed citations

11.

Hooper, Clare, Anna J. Morley, Paul Virgo, et al.. (2012). A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions. European Respiratory Journal. 41(1). 18–24. 23 indexed citations

12.

Irving, Julie, Paul Virgo, Marian Case, et al.. (2009). Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting;. Haematologica. 94(6). 870–874. 73 indexed citations

13.

Lock, R J, Paul Virgo, & D J Unsworth. (2008). Pitfalls in the performance and interpretation of clinical immunology tests. Journal of Clinical Pathology. 61(12). 1236–1242. 1 indexed citations

14.

Goulden, Nick, Paul Virgo, & David Grimwade. (2006). Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now. British Journal of Haematology. 134(3). 273–282. 16 indexed citations

15.

Cox, Charlotte V., et al.. (2006). Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood. 109(2). 674–682. 106 indexed citations

16.

Steward, Colin G., Allison Blair, John Moppett, et al.. (2005). High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis. Biology of Blood and Marrow Transplantation. 11(2). 115–121. 24 indexed citations

17.

Lock, R J, et al.. (2004). Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice. Clinical & Laboratory Haematology. 26(2). 101–106. 6 indexed citations

18.

Virgo, Paul, P. A. Denning‐Kendall, Connie L. Erickson‐Miller, et al.. (2003). Identification of the CD33‐related Siglec receptor, Siglec‐5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias. British Journal of Haematology. 123(3). 420–430. 20 indexed citations

19.

Gompels, Mark, et al.. (2002). A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. Journal of Clinical Pathology. 55(2). 145–147. 82 indexed citations

20.

Johnston, Sarah, Paul Virgo, & D J Unsworth. (2000). Type 1 diabetes mellitus masking primary antibody deficiency: Figure 1. Journal of Clinical Pathology. 53(3). 236–237. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact